Literature DB >> 19941070

Does Arkadia contribute to TGF-β1-induced IgA expression through up-regulation of Smad signaling in IgA nephropathy?

Xiao-Zhao Li1, Jun-Tao Feng, Cheng-Ping Hu, Ze-Qi Chen.   

Abstract

Immunoglobulin A nephropathy (IgAN) is an immune-complex-mediated glomerulonephritis characterized by the presence of IgA deposits in mesangial and paramesangial regions. However, the exact mechanism involved in IgA deposition is still unknown. TGF-β(1) that mediates the progression of IgAN is well established as a critical IgA class (isotype) switching factor, and Smad proteins are critical intracellular mediators in the expression of TGF-β(1)-targeted genes, which suggest that TGF-β signaling has been implicated in the primary pathogenesis of IgAN. Arkadia, an E3 ubiquitin ligase, can amplify TGF-β signaling through regulating Smads degradation. When these findings are considered together, it is of interest to explore how Arkadia and Smad signaling affect TGF-β(1)-induced IgA expression in IgAN. Therefore, we propose that Arkadia could positively contribute to TGF-β(1)-induced IgA secretion through up-regulation of Smad signaling in the pathogenesis of IgAN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941070     DOI: 10.1007/s11255-009-9682-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice.

Authors:  F W van Ginkel; S M Wahl; J F Kearney; M N Kweon; K Fujihashi; P D Burrows; H Kiyono; J R McGhee
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

2.  Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy.

Authors:  Y Chihara; H Ono; T Ishimitsu; Y Ono; K Ishikawa; H Rakugi; T Ogihara; H Matsuoka
Journal:  Clin Nephrol       Date:  2006-06       Impact factor: 0.975

Review 3.  Immunoglobulin class switching.

Authors:  J Stavnezer
Journal:  Curr Opin Immunol       Date:  1996-04       Impact factor: 7.486

Review 4.  TGF-beta in kidney fibrosis: a target for gene therapy.

Authors:  W A Border; N A Noble
Journal:  Kidney Int       Date:  1997-05       Impact factor: 10.612

5.  The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy.

Authors:  Qing Zhong; Joseph C K Leung; Loretta Y Y Chan; Anita W L Tsang; Xian Chen; Kar Neng Lai
Journal:  Am J Chin Med       Date:  2005       Impact factor: 4.667

6.  Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching.

Authors:  Seok-Rae Park; Goo-Young Seo; Ae-Jin Choi; Janet Stavnezer; Pyeung-Hyeun Kim
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

7.  Stimuli that enhance IgA class switching increase histone 3 acetylation at S alpha, but poorly stimulate sequential switching from IgG2b.

Authors:  Denise A Kaminski; Janet Stavnezer
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

8.  Opposing effects of Arkadia and Smurf on TGFbeta1-induced IgA isotype expression.

Authors:  Seo-Hyun Choi; Goo-Young Seo; Eun-Hee Nam; Seong-Hyun Jeon; Hyun-A Kim; Jae-Bong Park; Pyeung-Hyeun Kim
Journal:  Mol Cells       Date:  2007-10-31       Impact factor: 5.034

9.  Arkadia regulates TGF-beta signaling during renal tubular epithelial to mesenchymal cell transition.

Authors:  F-Y Liu; X-Z Li; Y-M Peng; H Liu; Y-H Liu
Journal:  Kidney Int       Date:  2007-12-05       Impact factor: 10.612

10.  Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis.

Authors:  Fu-You Liu; Xiao-Zhao Li; You-Ming Peng; Hong Liu; Ying-Hong Liu
Journal:  Am J Nephrol       Date:  2007-03-07       Impact factor: 3.754

View more
  1 in total

1.  Elucidation of the CHO Super-Ome (CHO-SO) by Proteoinformatics.

Authors:  Amit Kumar; Deniz Baycin-Hizal; Daniel Wolozny; Lasse Ebdrup Pedersen; Nathan E Lewis; Kelley Heffner; Raghothama Chaerkady; Robert N Cole; Joseph Shiloach; Hui Zhang; Michael A Bowen; Michael J Betenbaugh
Journal:  J Proteome Res       Date:  2015-10-13       Impact factor: 4.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.